LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
Public to see impact of medical research funding
Europe's largest store of open-access biomedical literature has joined forces with a leading online research outcomes system to connect research articles and grants with data on their impact. Europe PubMed Central (Europe PMC), a public archive of 28 million abstracts and 2.6 million full-text articles, has teamed with Researchfish, an online system for tracking and reporting on research outcomes.

Researchers, funders and members of the public will now find it easier to see which funding bodies have backed a given scientific article. Using Researchfish, researchers can link grant information to the unique ID (PubMed ID) of an article, but now Europe PMC will automatically make this information publicly available and easily searchable. Already, the collaboration has led to the pairing of over 80,000 grants and articles.

Many more funders now have the ability to highlight the value of the research they support; once the funding source has been linked to an article, it is possible to see the number of times an article has been cited by other research articles – in just a few clicks.

 Smaller medical research organizations stand to gain the most from the new venture. Asthma UK, a leading research charity, can now more easily report back to their donors on the success of their funding, now that Europe PMC is integrated with Researchfish.

 Malayka Rahman, Asthma UK's Research Analysis and Communications Officer said: “The collaboration has become an essential tool for us. Being able to report on longer term impacts is more important than ever for research charities - and having access to this linked research information through Europe PubMed Central and Researchfish is fantastic.

 “The Researchfish system is now much more powerful with Europe PMC.  The citation feature enables us to follow a research story from the beginning and see where it leads.  This will be a huge help when we feed back to our supporters and could transform the way we show them where their money is going. We can now trace how Asthma UK funded research has been developed and built on, and how it might link to a ground-breaking new treatment.”

“With this new development funders will be able to work together to demonstrate the impact of research spend on the health and wellbeing of the public, which in turn strengthen the case for investing in medical research.”

Jo McEntyre, who leads the development of Europe PMC at the EMBL-European Bioinformatics Institute, said: “Connecting grants to publications has always been tricky. As several leading medical charities use Researchfish for reporting grant outcomes, we thought this was a company we should talk to. Now, for the first time, many of these charities can show the impact of specific grants though the articles in Europe PMC. This innovation will ultimately lead to increased accountability and transparency for everyone. What's really great is that the data on grants and outcomes comes directly from the researcher, so we know it is the most accurate.”

Frances Buck, Director of Researchfish said: “The integration of these two systems presents an amazing opportunity for funding bodies and members of the public to see the origin and impact of ground-breaking research. We are delighted to be working with Europe PMC on this exciting project.”

Click here for the complete issue.

news Runners' High, Happy Feet — If you're Happy, and you know it 'Clap' your Feet
news Snapshot of Stem Cell Expression using Single-cell RNA Sequencing
news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy